Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2015
01/27/2015US8940862 Selective anticancer chimeric peptides which bind transferrin receptor
01/27/2015US8940857 Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
01/27/2015US8940732 Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway
01/27/2015US8940713 Micro-RNA family that modulates fibrosis and uses thereof
01/27/2015US8940712 Micro-RNA family that modulates fibrosis and uses thereof
01/27/2015US8940711 Micro-RNA family that modulates fibrosis and uses thereof
01/27/2015US8940709 Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules
01/27/2015US8940708 Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
01/27/2015US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
01/27/2015US8940536 Methods for making somatic cells more susceptible to reprogramming
01/27/2015US8940534 Immortalized avian cell lines for virus production
01/27/2015US8940533 Mouse artificial chromosome vector
01/27/2015US8940519 Method of producing a lipolytic enzyme
01/27/2015US8940515 Polypeptides having xylanase activity and polynucleotides encoding same
01/27/2015US8940514 Thioesterase and a method of producing fatty acids or lipids using the thioesterase
01/27/2015US8940509 Microorganisms and methods for the production of caprolactone
01/27/2015US8940504 Host cell protein knock-out cells for production of therapeutic proteins
01/27/2015US8940502 Nucleic acid constructs and methods of making protein
01/27/2015US8940479 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity
01/27/2015US8940310 Methods of treatment using TLR7 and/or TLR9 inhibitors
01/27/2015US8940299 Method of treating cancer
01/27/2015US8940296 Kits for segregating target nucleic acid from mixed nucleic acid samples
01/27/2015US8940290 Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
01/27/2015US8940289 Fusion molecules and IL-15 variants
01/27/2015US8939376 Encoding of microcarriers
01/27/2015CA2842232C Systems and methods to perform assays for detecting or quantifying analytes within samples
01/27/2015CA2733866C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
01/27/2015CA2705841C Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same
01/27/2015CA2695264C Enrichment of a target sequence
01/27/2015CA2632094C Carbonic anhydrase ix (g250) antibodies and methods of use thereof
01/27/2015CA2626423C Detection of primary infections with pathogens
01/27/2015CA2610405C Mannitol induced promoter systems in bacterial host cells
01/27/2015CA2603453C 5-fluorouracil-resistant bacteria and method for production thereof
01/27/2015CA2597730C Peptides for detection of antibody to ehrlichia ewingii
01/27/2015CA2575901C A method of treating cancer comprising a vegf-b antagonist
01/27/2015CA2515699C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
01/27/2015CA2501653C Human anti-ifn-.gamma. neutralizing antibodies as selective ifn-.gamma. pathway inhibitors
01/27/2015CA2488441C Synthetic antibody phage libraries
01/27/2015CA2483285C Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
01/27/2015CA2480311C Oligomeric compounds for the modulation of hif-1alpha expression
01/27/2015CA2470104C Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
01/27/2015CA2438133C Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
01/27/2015CA2298015C Production of erythropoietin by endogenous gene activation
01/26/2015CA2857774A1 Variety corn line iq1883
01/26/2015CA2857771A1 Variety corn line gaq2011
01/26/2015CA2857768A1 Variety corn line id2516
01/26/2015CA2857767A1 Variety corn line hba2544
01/26/2015CA2857766A1 Variety corn line gna0098zl
01/24/2015CA2857476A1 Variety corn line af3605
01/22/2015WO2015010114A1 Methods and compositions for producing double allele knock outs
01/22/2015WO2015010075A1 Multiplex assay for the detection of at least two citrus pathogens
01/22/2015WO2015010073A1 Attenuated influenza vaccines and uses thereof
01/22/2015WO2015010030A1 Methods of improving titer in transfection-based production systems using eukaryotic cells
01/22/2015WO2015010026A2 Compositions and methods for controlling leptinotarsa
01/22/2015WO2015009952A1 Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production
01/22/2015WO2015009853A1 Compositions for mucusal delivery, useful for treating papillomavirus infections
01/22/2015WO2015009802A1 Methods and systems for utilizing sperm for molecular delivery
01/22/2015WO2015009666A1 Suppression of silencing by gwar proteins
01/22/2015WO2015008985A1 Detection of target nucleic acid sequence by pto cleavage and extension-dependent immobilized oligonucleotide hybridization
01/22/2015WO2015008885A1 Method for diagnosing cervical cancer and diagnostic kit therefor
01/22/2015WO2015008644A1 Method for adjusting expression of hydroxymethylglutaryl coa reductase using bzip-type transcription factor, isoprenoid-producing plant into which gene encoded for bzip-type transcription factor is introduced, and method for manufacturing polyisoprenoid in which said plant is used
01/22/2015WO2015008637A1 Xanthine oxidase gene and amino acid sequence encoding same
01/22/2015WO2015008508A1 Nucleic acid chromatography
01/22/2015WO2015008320A1 Gene spatial distribution analysis system for cell tissue
01/22/2015WO2015007871A2 Micrornas and autoimmune-immune mediated inflammatory disease
01/22/2015WO2015007800A1 Method for extracting and purifying nucleic acids and buffers used
01/22/2015WO2015007748A1 Diterpene production
01/22/2015WO2015007536A2 Fusokines involving cytokines with strongly reduced receptor binding affinities
01/22/2015WO2015007383A1 Solid phase transfection of proteins and nucleic acids
01/22/2015WO2015007241A1 Molecular marker
01/22/2015WO2015007240A1 Transgenic maize
01/22/2015WO2015007216A1 Polypeptide, dna molecule encoding the polypeptide, vector, preparation method and use
01/22/2015WO2015007194A1 Method for plant genome site-directed modification
01/22/2015WO2015007033A1 Mutant of xylanase xynas9-m with improved thermal stability and gene and use thereof
01/22/2015WO2015006864A1 Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles
01/22/2015WO2014190273A9 Chimeric antigen receptor-targeting monoclonal antibodies
01/22/2015US20150026845 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc
01/22/2015US20150026844 Transgenic bioluminescent plants
01/22/2015US20150026841 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof
01/22/2015US20150026840 Constructs and systems and methods for producing microcompartments
01/22/2015US20150026837 Soybean cultivar ua5612
01/22/2015US20150026835 Watermelon variety tcs-ej09137
01/22/2015US20150025232 Heptamer-type small guide nucleic acids inducing apoptosis of human leukemia cells
01/22/2015US20150025231 Compositions and methods for modulation of ikbkap splicing
01/22/2015US20150025228 Igg fc fragment for a drug carrier and method for the preparation thereof
01/22/2015US20150025227 Igg fc fragment for a drug carrier and method for the preparation thereof
01/22/2015US20150025127 Compositions and methods for inducing apoptosis
01/22/2015US20150025124 Compositions and Methods for the Suppression of Target Polynucleotides from Lepidoptera
01/22/2015US20150025122 Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
01/22/2015US20150025045 CBP AND p300-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS
01/22/2015US20150025017 Compositions and methods for treating cancer
01/22/2015US20150024990 Subtilase Variants
01/22/2015US20150024971 Combined automated parallel synthesis of polynucleotide variants
01/22/2015US20150024959 METHOD FOR AMPLIFYING cDNA DERIVED FROM TRACE AMOUNT OF SAMPLE
01/22/2015US20150024957 Methods and Devices for Detection and Measurement of Analytes
01/22/2015US20150024954 Aptamer regulated nucleic acids and uses thereof
01/22/2015US20150024945 Systems and methods for sequencing in emulsion based microfluidics
01/22/2015US20150024944 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
01/22/2015US20150024500 Methods and compositions for producing double allele knock outs
01/22/2015US20150024499 Modified cascade ribonucleoproteins and uses thereof
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 4023